Aarti Drugs rises as Q2 profit climbs 83.2%

Aarti Drugs gained over 6.5% on 4 November 2026 as Q2 profit rose 83.2%. Rs 535 is resistance, while Rs 450 remains the key support level today. Aarti Drugs Ltd. [

] rose more than 6.5% in morning trade on 4 November 2026. Its consolidated Q2 profit increased 83.2% year on year to Rs 82.9 crore from Rs 45.3 crore. Revenue grew 26.6% year on year to Rs 826.2 crore from Rs 652.8 crore. Profit grew faster than revenue, pointing to stronger earnings growth in the quarter. The share has rallied 34.7% from its 24 October 2026 low. The current price is 475, 12.6% from the Rs 535 resistance. Rs 450 is the stated support. In my view, short-term momentum remains bullish after the sharp advance, though the rally may pause or see profit-taking. A move above Rs 535 would bring further strength into focus. A fall below Rs 450 would weaken the bullish view and put the advance under pressure. Watch the price reaction near Rs 535 and whether Rs 450 holds on a decline. The current price and chart structure should be checked against the latest trading screen. Stance: bullish in the short term while above Rs 450, with Rs 450 as the key support. Disclaimer: I do not hold any position in this. This content is for informational purposes only and is not a recommendation to buy or sell. Investments in securities are subject to market risks. Please read all related documents carefully before investing.